Aprea Therapeutics Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

1.66

-0.09 (-5.14%)

At close: Apr 29, 2025, 3:59 PM

1.66

0.00%

After-hours: Apr 29, 2025, 04:01 PM EDT

Aprea Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-12.96M	-14.29M	-112.66M	-37.13M	-53.48M	-28.06M	-15.53M	-15.19M
Depreciation & Amortization	22.32K	7.05K	186.44K	271.68K	229.61K	170.25K	8.32K	7.93K
Stock-Based Compensation	489.44K	444.46K	16.98M	7.81M	4.98M	1.35M	329.18K	395.44K
Other Working Capital	-741.19K	791.25K	-900.07K	-5.6M	3.25M	725.75K	687.47K	1.12M
Other Non-Cash Items	-54.37K	38.93K	72.24M	-317.4K	890.25K	-1.33M	-961.32K	-662.14K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.06M	1.62M	-1.76M	-8.33M	5.57M	1.16M	901.85K	1.45M
Operating Cash Flow	-13.56M	-12.18M	-25.01M	-37.69M	-41.8M	-26.71M	-15.25M	-14M
Capital Expenditures	-15.48K	-93.09K	n/a	n/a	-25.71K	-30.9K	-3.7K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-15.48K	-93.09K	n/a	n/a	-25.71K	-30.9K	-3.7K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.32M	-648.93K	n/a	208.37K	150.95K	71K	2.1K	n/a
Financial Cash Flow	14.82M	5.14M	682.97K	1.75M	150.95K	92.58M	56.37M	23.34M
Net Cash Flow	1.24M	-7.14M	-24.29M	-35.94M	-41.07M	64.41M	41.27M	10.74M
Free Cash Flow	-13.57M	-12.27M	-25.01M	-37.69M	-41.83M	-26.74M	-15.25M	-14M